{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:26:27Z","timestamp":1762503987327,"version":"build-2065373602"},"reference-count":65,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T00:00:00Z","timestamp":1402358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>The surgical management of malignant melanoma historically called for wide excision of skin and subcutaneous tissue for any given lesion, but has evolved to be rationally-based on pathological staging. Breslow and Clark independently described level and thickness as determinant in prognosis and margin of excision. The American Joint Committee of Cancer (AJCC) in 1988 combined features from each of these histologic classifications, generating a new system, which is continuously updated and improved.  The National Comprehensive Cancer Network (NCCN) has also combined several large randomized prospective trials to generate current guidelines for melanoma excision as well. In this article, we reviewed: (1) Breslow and Clark classifications, AJCC and NCCN guidelines, the World Health Organization\u2019s 1988 study, and the Intergroup Melanoma Surgical Trial; (2) Experimental use of Mohs surgery for in situ melanoma; and (3) Surgical margins and utility and indications for sentinel lymph node biopsy (SLNB) and lymphadenectomy. Current guidelines for the surgical management of a primary melanoma of the skin is based on Breslow microstaging and call for cutaneous margins of resection of 0.5 cm for MIS, 1.0 cm for melanomas \u22641.0 mm thick, 1\u20132 cm for melanoma thickness of 1.01\u20132 mm, 2 cm margins for melanoma thickness of 2.01\u20134 mm, and 2 cm margins for melanomas &gt;4 mm thick. Although the role of SLNB, CLND, and TLND continue to be studied, current recommendations include SLNB for Stage IB (includes T1b lesions \u22641.0 with the adverse features of ulceration or \u22651 mitoses\/mm2) and Stage II melanomas. CLND is recommended when sentinel nodes contain metastatic deposits.<\/jats:p>","DOI":"10.3390\/healthcare2020234","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T11:50:51Z","timestamp":1402401051000},"page":"234-249","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Update and Review on the Surgical Management of Primary Cutaneous Melanoma"],"prefix":"10.3390","volume":"2","author":[{"given":"Solmaz","family":"Leilabadi","sequence":"first","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Keck School of Medicine,  University of Southern California, 1510 San Pablo St., Suite 415, Los Angeles, CA 90015, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amie","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Keck School of Medicine,  University of Southern California, 1510 San Pablo St., Suite 415, Los Angeles, CA 90015, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy","family":"Tsai","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Keck School of Medicine,  University of Southern California, 1510 San Pablo St., Suite 415, Los Angeles, CA 90015, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinaya","family":"Soundararajan","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Keck School of Medicine,  University of Southern California, 1510 San Pablo St., Suite 415, Los Angeles, CA 90015, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Silberman","sequence":"additional","affiliation":[{"name":"Department of Surgery, Keck School of Medicine, University of Southern California,  1510 San Pablo St., Suite 412, Los Angeles, CA 90015, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Wong","sequence":"additional","affiliation":[{"name":"Division of Plastic and Reconstructive Surgery, Keck School of Medicine,  University of Southern California, 1510 San Pablo St., Suite 415, Los Angeles, CA 90015, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2014,6,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.clindermatol.2012.08.015","article-title":"Historical review of melanoma treatment and outcomes","volume":"31","author":"Lee","year":"2013","journal-title":"Clin. Dermatol."},{"key":"ref_2","first-page":"927","article-title":"The pathology of melanotic growths in relation to their operative treatment","volume":"1","author":"Handley","year":"1907","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2230.2000.00691.x","article-title":"Surgical management of primary melanoma","volume":"25","author":"Kaufmann","year":"2000","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_4","unstructured":"Edge, S.B., Byrd, D.R., Compton, C.C., Fritz, A.G., Greene, F.L., and Trotti, A. (2010). AJCC Cancer Staging Manual, Springer. [7th ed.]."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.det.2012.04.009","article-title":"Surgical treatment of malignant melanoma practical guidelines","volume":"30","author":"Levine","year":"2012","journal-title":"Dermatol. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10434-000-0087-9","article-title":"Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial","volume":"7","author":"Balch","year":"2000","journal-title":"Ann. Surg. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1056\/NEJM198805053181804","article-title":"Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm","volume":"318","author":"Veronesi","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.6004\/jnccn.2012.0036","article-title":"Melanoma: Clinical Practice Guidelines in Oncology","volume":"10","author":"Coit","year":"2012","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_10","unstructured":"Balch, C. (1992). Cutaneous Melanoma, JB Lippincott. [2nd ed.]."},{"key":"ref_11","unstructured":"Australian Cancer Network Melanoma Guidelines Revision Working Party (2008). Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand, Sydney and New Zealand Guidelines Group, The Cancer Council Australia, Australian Cancer Network."},{"key":"ref_12","unstructured":"Coit, D.G., Thompson, J.A., Andtbacka, R., Anker, C.J., Bichakjian, C.K., Carson, W.E., Daniels, G.A., Daud, A., DiMaio, D., and Fleming, M.D. Melanoma, Version 2.2014. Available online:http:\/\/www.nccn.org\/."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-4632.2010.04423.x","article-title":"Treatment options in melanoma in situ: Topical and radiation therapy, excision and Mohs surgery","volume":"49","author":"Erickson","year":"2010","journal-title":"Int. J. Derm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/dsu.12335","article-title":"Comparison of outcomes for malignant melanoma of the face treated using mohs micrographic surgery and wide local excision","volume":"39","author":"Murynka","year":"2013","journal-title":"Dermatol. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.clindermatol.2008.09.018","article-title":"Mohs micrographic surgery for the treatment of malignant melanoma","volume":"27","author":"Whalen","year":"2009","journal-title":"Clin. Derm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0190-9622(97)80131-4","article-title":"Mohs Micrographic surgery for the treatment of primary cutaneous melanoma","volume":"37","author":"Zitelli","year":"1997","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.det.2012.04.010","article-title":"Mohs micrographic surgery for the treatment of melanoma","volume":"30","author":"Hui","year":"2012","journal-title":"Dermatol. Clin."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jaad.2011.06.019","article-title":"Surgical margins for melanoma in situ","volume":"66","author":"Kunishige","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_19","unstructured":"National Institutes of Health (1992). Diagnosis and Treatment of Early Melanoma. National Institutes of Health Consensus Development Conference Statement, January 27\u201329, 1992. NIH Consens. Statement, 10, 1\u201326."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJMoa030681","article-title":"Excision margins in high-risk malignant melanoma","volume":"350","author":"Thomas","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(11)61546-8","article-title":"2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: A randomized, multicenter trial","volume":"378","author":"Gillgren","year":"2011","journal-title":"Lancet"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF02303495","article-title":"Surgical margins and prognostic factors in patients with thick (>4 mm) primary melanoma","volume":"5","author":"Heaton","year":"1998","journal-title":"Ann. Surg. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/SLA.0b013e31828421e1","article-title":"The importance of adequate primary tumor excision margins and sentinel node biopsy in achieving optimal locoregional control for patients with thick primary melanomas","volume":"258","author":"Pasquali","year":"2013","journal-title":"Ann. Surg."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/107327480901600305","article-title":"Sentinel lymph node biopsy for melanoma: Indications and rationale","volume":"16","author":"Phan","year":"2009","journal-title":"Cancer Control."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s004230000143","article-title":"Principles of sentinel lymph node identification: Background and clinical implications","volume":"385","author":"Cochran","year":"2000","journal-title":"Langenbecks Arch. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1200\/JCO.2011.40.3519","article-title":"Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guidelines","volume":"30","author":"Wong","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1245\/s10434-012-2475-3","article-title":"Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guidelines","volume":"19","author":"Wong","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10585-012-9503-3","article-title":"Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma","volume":"29","author":"Morton","year":"2012","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s11864-012-0202-8","article-title":"Surgical treatment of melanoma patients with early sentinel node involvement","volume":"13","author":"Hardin","year":"2012","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejca.2005.10.012","article-title":"In transit\/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection","volume":"42","author":"Rutkowski","year":"2006","journal-title":"Eur. J. Cancer."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1468-3083.2000.00005.x","article-title":"Sentinel lymph node biopsy in patients with primary cutaneous melanoma: Study of 455 cases","volume":"14","author":"Landi","year":"2000","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/cncr.24895","article-title":"Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?","volume":"116","author":"Mays","year":"2010","journal-title":"Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients","volume":"17","author":"Gershenwald","year":"1999","journal-title":"J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.6004\/jnccn.2013.0192","article-title":"Progress in the management of melanoma in 2013","volume":"11","author":"Coit","year":"2013","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1245\/s10434-012-2826-0","article-title":"Sentinel node biopsy in thin and thick melanoma","volume":"20","author":"Mozzillo","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1245\/ASO.2006.05.011","article-title":"Predictors of regional nodal disease in patients with thin melanomas","volume":"13","author":"Karakousis","year":"2006","journal-title":"Ann. Surg. Oncol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.sla.0000090446.63327.40","article-title":"Thin melanomas: Predictive lethal characteristics from a 30-year clinical experience","volume":"238","author":"Kalady","year":"2003","journal-title":"Ann. Surg."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1245\/ASO.2005.04.027","article-title":"Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas","volume":"12","author":"Kesmodel","year":"2005","journal-title":"Ann. Surg. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1245\/ASO.2006.04.023","article-title":"The prognostic importance of sentinel lymph node biopsy in thin melanoma","volume":"13","author":"Ranieri","year":"2006","journal-title":"Ann. Surg. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00000658-199910000-00001","article-title":"Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: A multicenter trial. Multicenter Selective Lymphadenectomy Trial Group","volume":"230","author":"Morton","year":"1999","journal-title":"Ann. Surg."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00000658-199412000-00009","article-title":"The orderly progression of melanoma nodal metastases","volume":"220","author":"Reintgen","year":"1994","journal-title":"Ann. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative lymphatic mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008390-199508000-00008","article-title":"Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes","volume":"5","author":"Thompson","year":"1995","journal-title":"Melanoma Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/0194599811408554","article-title":"Sentinel node biopsy for head and neck melanoma: A systematic review","volume":"145","author":"Lyman","year":"2011","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.6004\/jnccn.2013.0055","article-title":"Melanoma, version 2.2013, featured updates to the NCCN guidelines","volume":"11","author":"Coit","year":"2013","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1046\/j.1365-2168.2002.02236.x","article-title":"Tumor thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy","volume":"89","author":"Lens","year":"2002","journal-title":"Br. J. Surg."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1067\/mjd.2001.112346","article-title":"Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas","volume":"44","author":"Cherpelis","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_48","first-page":"127","article-title":"Sentinel node biopsy should not be recommended for patients with thick melanoma","volume":"40","author":"Silva","year":"2013","journal-title":"Rev. Col. Bras. Cir."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1245\/s10434-008-9965-3","article-title":"The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3)","volume":"15","author":"Nowecki","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s10434-000-0160-4","article-title":"Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma","volume":"7","author":"Gershenwald","year":"2000","journal-title":"Ann. Surg. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1245\/s10434-008-9888-z","article-title":"Criteria in sentinel lymph nodes of melanoma patients that predict involvement of nonsentinel lymph nodes","volume":"15","author":"Satzger","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejso.2007.01.027","article-title":"Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients","volume":"34","author":"Roka","year":"2008","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/modpathol.3800117","article-title":"Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node","volume":"17","author":"Cochran","year":"2004","journal-title":"Mod. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/01.cmr.0000136708.90534.71","article-title":"Immunohistochemical stains fail to increase the detection rate of micrometastatic melanoma in completion regional lymph node dissection specimens","volume":"14","author":"Scolyer","year":"2004","journal-title":"Melanoma Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1200\/JCO.2007.15.4179","article-title":"Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma","volume":"26","author":"Gershenwald","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejca.2003.07.003","article-title":"Patients with lymphatic metastasis of cutaneous malignant melanoma benefit from sentinel lymphonodectomy and early excision of their nodal disease","volume":"40","author":"Kretschmer","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/01.sla.0000086543.45557.cb","article-title":"Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: Therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases","volume":"238","author":"Morton","year":"2003","journal-title":"Ann. Surg."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cncr.24852","article-title":"Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases: Personal experience and literature meta-analysis","volume":"116","author":"Pasquali","year":"2010","journal-title":"Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0748-7983(03)00118-5","article-title":"Lymph node status and survival in cutaneous malignant melanoma\u2014Sentinel lymph node biopsy impact","volume":"29","author":"Rutkowski","year":"2003","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.suronc.2009.09.004","article-title":"Prognostic heterogeneity after the excision of lymph node metastases in patients with cutaneous melanoma","volume":"20","author":"Pilko","year":"2011","journal-title":"Surg. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/01.sla.0000250942.84678.8b","article-title":"Sentinel node biopsy for early-stage melanoma: Accuracy and morbidity in MSLT-1, an international multicenter trial","volume":"245","author":"Twomey","year":"2007","journal-title":"Ann. Surg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/jso.20084","article-title":"Lessons learned from the Sunbelt melanoma trial","volume":"86","author":"McMasters","year":"2004","journal-title":"J. Surg. Oncol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"E8645","DOI":"10.1136\/bmj.e8645","article-title":"Sentinel node biopsy for melanoma: Unnecessary treatment?","volume":"346","author":"Torjesen","year":"2013","journal-title":"Br. Med. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1002\/cncr.28229","article-title":"Physicians differ on the use of Sentinel lymph node biopsy for melanoma: Published data receive various interpretations","volume":"119","author":"Printz","year":"2013","journal-title":"Cancer"}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/2\/2\/234\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:12:16Z","timestamp":1760217136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/2\/2\/234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,10]]},"references-count":65,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,6]]}},"alternative-id":["healthcare2020234"],"URL":"https:\/\/doi.org\/10.3390\/healthcare2020234","relation":{},"ISSN":["2227-9032"],"issn-type":[{"type":"electronic","value":"2227-9032"}],"subject":[],"published":{"date-parts":[[2014,6,10]]}}}